CRISPR Medicine News, 11 January 2021 | In Vivo Base Editing Corrects Rare Retinal Disease - CRISPR Medicine
(ad)
(ad)Learn More

In Vivo Base Editing Corrects Rare Retinal Disease and Restores Sight in Animal Model

In vivo base editing has been shown to correct the inherited eye disease Leber congenital amaurosis in an animal retinal disease model. These first proof-of-concept experiments from Krzysztof Palczewski's lab at University of California, Irvine, point to a whole new treatment modality for this devastating disease. Read more about it in our interview with co-first author Susie Suh.

Career CRISPR Medicine

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at editor@crisprmedicinenews.com. We love hearing from readers!

Happy Reading!

Karen

p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.

(ad)

CRISPR QC pioneers streamlined and automated CRISPR quality control tools to accelerate research while improving accuracy and performance.

(ad)
Read more...
(ad)
(ad)

Call for Papers:

Frontiers in Genome Editing

Open for submissions:

Abstract Deadline: 1st February 2021

Final Manuscript Deadline: 2nd May 2021

Read more...